Thermo Fisher Scientific Short-Term Investments decreased by 83.8% to $253.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 83.8%, from $1.56B to $253.00M. Over 2 years (FY 2023 to FY 2025), Short-Term Investments shows an upward trend with a 818.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
High levels indicate strong cash generation exceeding immediate operational needs; a sharp decline might suggest a shift toward long-term projects or acquisitions.
Marketable securities and debt instruments that the company intends to sell or that will mature within one year. This me...
Commonly high in the software industry where low capital intensity leads to significant excess capital.
short_term_investments| Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $3.00M | $1.75B | $1.75B | $2.00B | $1.56B | $1.81B | $1.81B | $1.56B | $253.00M |
| QoQ Change | — | >999% | -0.1% | +14.3% | -21.9% | +16.1% | +0.1% | -13.8% | -83.8% |
| YoY Change | — | — | — | — | >999% | +3.5% | +3.7% | -21.8% | -83.8% |
We use cookies for analytics. See our Privacy and Cookie Policy.